PALIVIZUMAB FOR PROPHYLAXIS AGAINST RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN CHILDREN WITH CYSTIC FIBROSIS: RESULTS OF A COCHRANE SYSTEMATIC REVIEW

被引:0
|
作者
Saldanha, I. [1 ]
Mckoy, N. A. [1 ]
Robinson, K. A. [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:331 / 331
页数:1
相关论文
共 50 条
  • [21] COST-EFFECTIVENESS OF PROPHYLAXIS OF RESPIRATORY SYNCYTIAL VIRUS INFECTION (RSV) WITH PALIVIZUMAB IN PRETERM INFANTS IN COLOMBIA
    Rosselli, D.
    Rueda, J. D.
    Ruiz, J. G.
    VALUE IN HEALTH, 2013, 16 (03) : A75 - A75
  • [22] Prevention of respiratory syncytial virus (RSV) infection: RSV immune globulin intravenous and palivizumab
    Canfield, SD
    Simoes, EAF
    PEDIATRIC ANNALS, 1999, 28 (08): : 507 - +
  • [23] Efficacy and Safety of Palivizumab as a Prophylaxis for Respiratory Syncytial Virus (RSV) Disease: An Updated Systemic Review and MetaAnalysis
    El-Atawi, Khaled
    De Luca, Daniele
    Ramanathan, Ranagasamy
    Luna, Manuel Sanchez
    Alsaedi, Saad
    Wahab, Muzafar Gani Abdul
    Hamdi, Moataz
    Saleh, Maysa
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [24] CHILDREN HOSPITALIZED WITH RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION AFTER PALIVIZUMAB PROPHYLAXIS IN TWO LARGE PAEDIATRIC TERTIARY CARE CENTERS
    Rajakumar, D.
    Tan, B.
    Bodani, J.
    Zhu, T.
    Janzen, B.
    Bodani, R.
    Kurji, A.
    Sharma, A.
    McConnell, A.
    Kalapurackal, M.
    Sankaran, K.
    ACTA PAEDIATRICA, 2009, 98 : 214 - 215
  • [25] Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005-2016)
    Mitchell, Ian
    Wong, S. K.
    Paes, B.
    Ruff, M.
    Bjornson, C.
    Li, A.
    Lanctot, K. L.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2018, 37 (07) : 1345 - 1352
  • [26] Treatment of respiratory syncytial virus with palivizumab: a systematic review
    Hu, Jia
    Robinson, Joan L.
    WORLD JOURNAL OF PEDIATRICS, 2010, 6 (04) : 296 - 300
  • [27] Treatment of respiratory syncytial virus with palivizumab: a systematic review
    Jia Hu
    Joan L. Robinson
    World Journal of Pediatrics, 2010, 6 : 296 - 300
  • [28] Is palivizumab effective as a prophylaxis of respiratory syncytial virus infections in cystic fibrosis patients? A meta-analysis
    Sanchez-Solis, M.
    Gartner, S.
    Bosch-Gimenez, V.
    Garcia-Marcos, L.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2015, 43 (03) : 298 - 303
  • [29] Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
    Poshtiban, Anahita
    Wick, Moritz
    Bangert, Mathieu
    Damm, Oliver
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
  • [30] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection
    Scholz, H
    ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122